Inhaled cannabis or extracted cannabinoids are considered investigational for the treatment of the following:
Chronic non-cancer pain
Cancer pain
Acute post-operative pain
Spasticity associated with multiple sclerosis.
Inhaled cannabis or extracted cannabinoids are considered investigational for all other conditions that have not received approval from the U.S. Food and Drug Administration.